This information can support conversations with your provider about personalized expectations, potential titration strategies, and monitoring approaches
Lets explore these factors in detail to understand why fainting can occur and how to prevent it
Natural GLP-1 secretion in the body follows a circadian pattern
Here is a framework for creating meals that work with the medication rather than against it
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated greater efficacy in clinical trials, including the head-to-head SURMOUNT-5 trial comparing it to semaglutide 2.4 mg, potentially producing more substantial weight loss than traditional GLP-1 agonists alone
History of suicidal thinking Non-medullary thyroid cancer A family history of multiple endocrine neoplasia type 2 Because GLP-1s target the root causes of weight gain, many patients experience sustained weight loss after stopping the medication